Chenlin Su

1 Introduction Colorectal cancer (CRC) is a major global public health challenge, ranking as the third most prevalent malignancy and the second leading cause of cancer-related mortality worldwide (1). The emergence of precision oncology has begun to transform cancer treatment, moving beyond a one-size-fits-all approach to embrace therapies tailored to the genetic and molecular profile of an individual’s tumor.

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.